We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$128B
AUM Growth
+$15.2B
Cap. Flow
+$9.11B
Cap. Flow %
7.13%
Top 10 Hldgs %
13.82%
Holding
11,531
New
1,109
Increased
4,588
Reduced
4,144
Closed
1,087

Sector Composition

Rank Sector Weight
1 Energy 8.83%
2 Technology 6.7%
3 Healthcare 6.28%
4 Financials 6.28%
5 Industrials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USLM icon
8651
United States Lime & Minerals
USLM
$3.24B
$12K ﹤0.01%
+925
New +$11.1K
VICR icon
8652
Vicor
VICR
$8.33B
$12K ﹤0.01%
1,432
-3,581
-71% -$29.1K
IVAC
8653
DELISTED
Intevac Inc
IVAC
$12K ﹤0.01%
1,473
-41,161
-97% -$333K
INFN
8654
CALL
DELISTED
Infinera Corporation Common Stock
INFN
$12K ﹤0.01%
1,300
-5,700
-81% -$50.6K
HTLF
8655
DELISTED
Heartland Financial USA, Inc.
HTLF
$12K ﹤0.01%
500
-646
-56% -$16.1K
SRCL
8656
CALL
DELISTED
Stericycle Inc
SRCL
$12K ﹤0.01%
100
ENSV
8657
DELISTED
Enservco Corp.
ENSV
$12K ﹤0.01%
313
-260
-45% -$9.77K
VIVO
8658
PUT
DELISTED
Meridian Bioscience Inc
VIVO
$12K ﹤0.01%
600
+200
+50% +$4.11K
IMLP
8659
DELISTED
iPath S&P MLP ETN
IMLP
$12K ﹤0.01%
+350
New +$11.1K
AGTC
8660
DELISTED
Applied Genetic Technologies Corporation
AGTC
$12K ﹤0.01%
+511
New +$9K
MBII
8661
DELISTED
Marrone Bio Innovations, Inc.
MBII
$12K ﹤0.01%
1,032
+719
+230% +$8.15K
ADMS
8662
DELISTED
Adamas Pharmaceuticals
ADMS
$12K ﹤0.01%
+634
New +$11.4K
CZZ
8663
CALL
DELISTED
Cosan Limited
CZZ
$12K ﹤0.01%
+900
New +$11.5K
TLRA
8664
DELISTED
Telaria, Inc.
TLRA
$12K ﹤0.01%
2,515
-54,064
-96% -$231K
MDCO
8665
CALL
DELISTED
Medicines Co
MDCO
$12K ﹤0.01%
400
LION
8666
DELISTED
Fidelity Southern Corporation
LION
$12K ﹤0.01%
920
-496
-35% -$6.69K
ELLI
8667
DELISTED
Ellie Mae Inc
ELLI
$12K ﹤0.01%
400
-4,337
-92% -$116K
JONE
8668
DELISTED
Jones Energy, Inc.
JONE
$12K ﹤0.01%
32
-115
-78% -$35.5K
REIS
8669
DELISTED
Reis, Inc.
REIS
$12K ﹤0.01%
573
+62
+12% +$1.14K
KND
8670
PUT
DELISTED
Kindred Healthcare
KND
$12K ﹤0.01%
500
-3,500
-88% -$85.6K
FINL
8671
CALL
DELISTED
Finish Line
FINL
$12K ﹤0.01%
400
+300
+300% +$8.52K
ABE
8672
DELISTED
Aberdeen Emerging Markets Smaller Company Opportunities Fund
ABE
$12K ﹤0.01%
852
-1,188
-58% -$16.5K
NASH
8673
DELISTED
Nashville Area ETF
NASH
$12K ﹤0.01%
+436
New +$11.7K
LUX
8674
CALL
DELISTED
Luxottica Group
LUX
$12K ﹤0.01%
200
-500
-71% -$28.3K
NRF
8675
PUT
DELISTED
NorthStar Realty Finance Corp.
NRF
$12K ﹤0.01%
356
-10,848
-97% -$342K

Similar funds

UBS's Q2 2014 Portfolio in Review

As of Q2 2014, UBS held 11,531 positions worth $128B, up 14% from $113B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $9.11B of net new capital in Q2 2014, opening 1,109 new positions and adding to 4,588 existing holdings. Its largest new stake was JD.com: 3,966,156 shares worth $113M.

By sector, the portfolio is most concentrated in Energy at 8.8% of assets, down from 9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Baker Hughes, an estimated $755M trimmed.

  • UBS's largest Q2 2014 buy was JD.com: 3,966,156 shares worth $113M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $1.71B increase.
  • UBS's biggest Q2 2014 reduction was Baker Hughes, cutting an estimated $755M.
  • UBS fully exited KKR FINANCIAL HOLDINGS LLC COM in Q2 2014, selling an estimated $47.8M.
  • UBS's ten largest holdings make up 14% of its $128B portfolio in Q2 2014.
  • UBS opened 1,109 new positions and closed 1,087 in Q2 2014.
  • UBS's portfolio value rose 14% quarter-over-quarter to $128B.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.